Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 1/20 | 0.47 |
| ▸ | PPARA | Q07869 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | ALPI | P09923 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | XIAP | P98170 | 1/20 | 0.44 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7054009 | 0.98 | PPARG (0.46) | PPARGPPARACYP1A2CYP2C19ALPI | |
| SCHEMBL11545644 | 0.93 | PPARG (0.47) | PPARGPPARACYP1A2CYP2C19ALPI | |
| Glycolic Acid SCHEMBL9427710 | 0.93 | CYP2C19 (0.44) | PPARGPPARACYP1A2CYP2C19ALPI | |
| SCHEMBL28173073 | 0.84 | SLC7A5 (0.47) | CYP2C19SLC7A5POLBSMN1; SMN2EPHX1 | |
| SCHEMBL9659013 | 0.82 | TDP1 (0.47) | PPARGPPARACYP1A2CYP2C19L3MBTL1 | |
| SCHEMBL28721831 | 0.82 | KEAP1 (0.47) | CYP1A2ALPIPKMPTGS1XIAP | |
| SCHEMBL6954426 | 0.81 | PPARG (0.49) | PPARGPPARACYP1A2CYP2C19ALPI | |
| SCHEMBL11599376 | 0.78 | ALDH1A1 (0.41) | PPARGPPARACYP1A2CYP2C19ATM | |
| SCHEMBL27978265 | 0.78 | PPARG (0.46) | PPARGPPARACYP1A2CYP2C19ALPI | |
| SCHEMBL44800 | 0.78 | L3MBTL1 (0.56) | PPARGPPARACYP1A2CYP2C19ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119050267-B | Positive electrode capable of limiting lattice oxygen escape and preparation method and application thereof | 华中科技大学 | 2026-05-12 | — | — | CN | claimed |
| CN-119050267-A | Positive electrode capable of limiting lattice oxygen escape and preparation method and application thereof | 华中科技大学 | 2024-11-29 | — | — | CN | claimed |
| CN-112964705-B | Reagent for detecting ethylenediamine by using dual modes of rapid colorimetric and fluorescent lighting | 中国科学院新疆理化技术研究所 | 2022-06-03 | — | — | CN | claimed |
| CN-112964705-A | Reagent for detecting ethylenediamine by using dual modes of rapid colorimetric and fluorescent lighting | 中国科学院新疆理化技术研究所 | 2021-06-15 | — | — | CN | claimed |
| CN-108425104-B | Preparation method of coating taking mercapto compound as transition layer | 江苏菲沃泰纳米科技有限公司 | 2020-02-18 | — | — | CN | claimed |
| US-7732625-B2 | Colorant compounds | XEROX CORPORATION (US) | 2010-06-08 | — | — | US | claimed |
| US-7311767-B2 | Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens | XEROX CORPORATION (US) | 2007-12-25 | — | — | US | claimed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| CN-119050267-B | Positive electrode capable of limiting lattice oxygen escape and preparation method and application thereof | 华中科技大学 | 2026-05-12 | — | — | CN | disclosed |
| EP-4577615-A1 | POLYMERIZABLE LIQUID CRYSTAL MATERIAL AND POLYMERIZED LIQUID CRYSTAL FILM | Merck Patent GmbH (DE) | 2025-07-02 | — | — | EP | disclosed |
| CN-119050267-A | Positive electrode capable of limiting lattice oxygen escape and preparation method and application thereof | 华中科技大学 | 2024-11-29 | — | — | CN | disclosed |
| US-4559372-A | ADDITIVES OF RED PHOSPHORUS AND A LANTHANIDE AND/OR YTTRIUM COMPOUND; NONTOXIC;ARC TRACKING RESISTANCE | RHONE-POULENC SPECIALITIES CHIMIQUES (FR) | 1985-12-17 | — | — | US | disclosed |
| EP-0136721-A2 | Carboxyalkenamidocephalosporins | SHIONOGI & CO., LTD. (JP) | 1985-04-10 | — | — | EP | disclosed |
| US-RE29523-E | Olefinic polymers stabilized with thioacyl trivalent phosphorus compounds | BORG-WARNER CORPORATION (US) | 1978-01-24 | — | — | US | disclosed |
| US-4021407-A | DISCOLORATION INHIBITION | CINCINNATI MILACRON, INC. (US) | 1977-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | PPARG 2617/4885PPARA 3447/4885CYP1A2 1066/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | PPARG 1856/4885PPARA 1646/4885CYP1A2 968/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.